Reproductive Health

Nature Study: Fairtility’s CHLOE AI Supports Academic Research in Assisted Reproductive Technologies

A recent study published in the Nature demonstrates the potential of CHLOE, an AI decision support technology developed by Fairtility, to advance academic research in reproductive health. The study led by Professor Iris Har Vardi, an authority in the field of fertility and IVF, specifically focused on the impact of blastocyst morphometric parameters on implantation potential. Professor Har Vardi, Director of Fertility…

Natural Cycles Gains FDA Clearance for Apple Watch Integration

Natural Cycles, the FDA-cleared and CE-marked birth control app, announced today that it has received 510(k) clearance from the U.S Food and Drug Administration (FDA) as well as from European regulators for integration with Apple Watch Series 8 and Apple Watch Ultra. Natural Cycles helps women looking to naturally prevent and plan pregnancy without hormones. The algorithm-powered app analyzes daily hormone-driven temperature…

Fertility Startup Mosie Baby Secures $1M in Funding to Support Retail Expansion

Austin-based startup Mosie Baby, a pioneer in at-home fertility solutions, has announced the launch of an updated Mosie Baby At-Home Insemination Kit and the successful closing of an oversubscribed bridge round with over $1M in funding. Founded in 2015, Mosie Baby addresses the challenges couples and individuals face when looking for affordable and comfortable fertility solutions. Created by Maureen and Marc Brown,…

Thermo Fisher Scientific Releases New Tools for Fertility Research

Thermo Fisher Scientific has launched two next-generation sequencing-based assays aimed at accelerating research in fertility and reproductive health. These tools are designed to work with the Ion Torrent Genexus Integrated Sequencer and are intended for research use only meaning they are not meant to be used in diagnostic procedures. Based in Carlsbad, California, Thermo Fisher Scientific has introduced the Ion ReproSeq PGT-A…

Mira Is the Highest Ranking Femtech Company on This Year’s Inc.’s 5000 List of Fastest Growing Companies in the US

Mira is a San Francisco-based company that provides healthcare products for more personal, accurate, and reliable home healthcare. Quanovate was founded in late 2015 by a group of scientists, engineers, OBGYN doctors, and business execs to solve the problem of the unavailability of advanced home health testing. The company’s mission is to make home healthcare more personalized and reliable, while empowering people…

Fertilly Introduces Europe’s First Home Fertility Test Leveraging Dry Blood Method

German healthtech startup Fertilly has recently launched Europe’s first home fertility test that utilizes the dry blood method. This technology allows women to gain precise insights into their fertility health using a few drops of dry blood from the comfort of their homes. The focal point of this test is the measurement of Anti-Müllerian Hormone (AMH) levels, a crucial indicator of ovarian…

Hey Jane Expands Its Virtual Health Services Beyond Abortion Care

Virtual abortion care provider Hey Jane is broadening its online services to include treatments for vaginal infections, birth control, and emergency contraception. This expansion seeks to provide a discreet and accessible solution for these reproductive and sexual health issues, leveraging their established digital healthcare platform. The process involves a brief patient intake, connecting them through Hey Jane’s secure messaging platform. This allows…

Pinnacle Fertility Expands Its Network with the Addition of Oma Fertility Clinics

In a strategic move aimed at expanding their national footprint, Pinnacle Fertility is adding four clinics from Oma Fertility, a budding entity known for its innovative approach to fertility care. The clinics, located in Atlanta, St. Louis, New York City, and Long Island, will now operate under the Pinnacle Fertility banner. Established in 2020, Oma Fertility carved a niche in the competitive…